Morningstar

DexCom Inc DXCM

Morningstar Rating
Unlock
Stock XNAS Rating as of
$67.10 +1.10 (1.67%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Dexcom Hit by Operational Issues That Put Revenue Growth and Margins Under Pressure

Debbie S. Wang

Dexcom enjoys a well-established track record for introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, Dexcom has captured an impressive slice of this CGM market, but a recent wave of innovation in the diabetes device market has intensified competitive pressure. Nonetheless, Dexcom has done a credible job of adapting and fending off competition from Abbott and Medtronic.

Read Full Report

Price vs Fair Value

View History
DXCM is trading at a 439% premium.
Price
$67.10
Fair Value
$42.00
Uncertainty
High
1-Star Price
$837.20
5-Star Price
$66.20
Economic Moat
Wsfkk
Capital Allocation
Vjskbzmhz

Bulls Say, Bears Say

Bulls

Dexcom's next-gen G7 product should be significantly less expensive, offer a thinner profile, and faster warm-up time than G6.

Bears

Considering Dexcom's sensors are already the most accurate, there's less opportunity for significant improvements on that dimension, compared with key competitors.

Show More

News

View All

Trading Information

Previous Close Price
$66.00
Day Range
$64.76–67.19
52-Week Range
$62.34–142.00
Bid/Ask
$67.10 / $67.33
Market Cap
$26.89 Bil
Volume/Avg
3.8 Mil / 5.4 Mil

Key Statistics

Price/Earnings (Normalized)
38.34
Price/Sales
7.17
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
1.76%

Company Profile

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Growth
Total Number of Employees
9,600
Website
https://www.dexcom.com

Competitors

Valuation

View More
Metric
DXCM
PODD
MDT
Price/Earnings (Normalized)
 38.3468.6217.01
Price/Book Value
 11.0516.342.38
Price/Sales
 7.179.373.61
Price/Cash Flow
 31.3744.1415.77
Price/Earnings
DXCM
PODD
MDT

Financial Strength

Metric
DXCM
PODD
MDT
Quick Ratio
 2.392.411.35
Current Ratio
 2.823.602.13
Interest Coverage
 35.337.037.66
Quick Ratio
DXCM
PODD
MDT

Profitability

Metric
DXCM
PODD
MDT
Return on Assets (Normalized)
 10.74%9.03%7.66%
Return on Equity (Normalized)
 31.84%31.74%13.69%
Return on Invested Capital (Normalized)
 12.04%11.10%9.84%
Return on Assets
DXCM
PODD
MDT

Medical Devices Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
MqqhszldMvxrzjt$197.7 Bil
 Stryker Corp
SYK
CdnvmspssgHhxm$135.3 Bil
 Boston Scientific Corp
BSX
NmbxphxZhfxd$124.4 Bil
 Medtronic PLC
MDT
KfrdjzmNfmxxsf$114.3 Bil
 Edwards Lifesciences Corp
EW
LkfhngsyDjpzfj$39.2 Bil
 Koninklijke Philips NV ADR
PHG
RktWxnhq$30.6 Bil
 Steris PLC
STE
PbxhbfkyvRwpgpg$23.1 Bil
 Zimmer Biomet Holdings Inc
ZBH
BpqjdzbvkYbrx$21.5 Bil
 Insulet Corp
PODD
XkrhhpgfdZrpdfc$16.3 Bil

Sponsor Center